Experts from the US have done a study to understand the efficiency of the first generation vaccines in preventing different variants of the SARS-CoV-2 virus. They have enrolled people who have been infected with the virus in the past in their study. The SARS-CoV-2 virus leads to COVID19 disease. The virus has claimed the lives of around 3.91 million people across the world. The virus continues to be a threat to global health. The team of experts has tested the levels of neutralizing antibodies against different strains of the virus before and after two doses of the Pfizer-BioNtech vaccine in ten people who have been diagnosed with the disease before vaccination. Experts have compared neutralizing titers with the neutralizing titers of people who have not been infected with the virus before vaccination. Scientists from Oregon Health and Science University in Portland have shown that vaccination has been able to shoot up pre-existing levels of antibodies by 10 fold in people who have been infected earlier as compared to people who have not been diagnosed with the disease. The spike protein in the SARS-CoV-2 virus helps it to infect host cells. The spike protein attaches to the human host cell receptor angiotensin-converting-enzyme 2 (ACE2) through its receptor-binding domain (RBD). RBD is the main target point of neutralizing antibodies that are developed after an infection or vaccination.
The study has shown that vaccination has shot up the level of neutralizing antibodies in people who have been infected earlier against the original strain and three other strains of the virus. Experts have seen that neutralizing titers in people with past infection have been five times higher against the B.1.1.7 strain that has been found in the UK for the first time. Neutralizing titers in people with past infection have been more than six times higher against the B.1.351 strain that has been found in South Africa. It has been more than four times potent against the strain that has been found in Brazil known as P.1. Since the COVID19 pandemic has started in 2019, many experts have come up with a wide range of vaccines that can protect people against the deadly virus. These vaccines have been proven to be effective in their clinical trials. These vaccines have been approved for emergency use in many countries.
With the large fraction of many communities gaining natural immunity against the virus via prior infection, the vaccination plans have raised the odds that a high level of herd immunity might be achieved soon. However, the surfacing of various strains of concern (VOCs) of the virus has created a doubt in experts’ minds. These strains have spike mutations that can shoot up the binding ability of the virus to host cells and its ability to spread. Experts have noted that there has been no major change between the post-vaccination neutralizing antibody titers against the B.1.351 variant of the virus in people who have been diagnosed with the disease earlier and those against the original strain in people who have not been infected ever. The study has shown that the first generation COVID19 vaccines have been quite effective against some deadly strains of the virus when it has been given after the first infection.
The global heat transfer fluid market is poised to grow at a CAGR of 5.6%…
The Calcium Hypochlorite market is poised for substantial growth, projected to reach around USD 2317.9…
The Sodium Metabisulfite Market is poised for significant growth, with a projected value of USD…
activated alumina market size is expected to be worth around USD 1724 Million by 2033, from USD 1018.9 Million…
The bio fungicides market is poised for significant growth, with projections indicating a valuation of…
The hydrogen generation market is forecasted to see substantial growth, reaching USD 489.2 billion by…
The Hydrogen Peroxide Market, valued at USD 3.2 Billion in 2023, is projected to exhibit…
The global bauxite market exhibited significant value and growth trends over recent years. In 2022,…
The aerogel market has demonstrated significant growth, with its valuation reaching USD 876.5 million in…
biobased disinfectant market size was valued at USD 4.5 Billion and it is estimated to reach USD 8.7 billion…
The Concrete Sealer Market is poised for substantial growth, with projections estimating its value to…
The Ammonium Sulfate Market is poised for significant growth, projected to reach approximately USD 6.1…
The cathode material market, integral to advancements in battery technology, has been valued at USD…
The flat glass market, known for its essential role in various industries, is on a…
The Special Graphite Market, valued at USD 785.5 million in 2022, is projected to reach…
The Black Pellets Market is poised for significant growth, with a projected Compound Annual Growth…
The nanosized alumina market, valued at $3.0 billion in 2022, is expected to grow to…
The global methanol market is on a robust growth trajectory, with projections indicating a rise…
The E-Liquids market is set to experience remarkable growth, with a projected Compound Annual Growth…
The PVC market is anticipated to achieve a substantial valuation of USD 94.7 billion by…